In vivo protective effect of crocetin on benzo(a)pyrene-induced lung cancer in swiss albino mice

Phytotherapy Research

Volumn 23, Issue 4, 2009, Pages 533-539

  Magesh, Venkatraman ^a   Bhavani, Konga Durga ^a   Senthilnathan, Palaniyandi ^a   Rajendran, Peramaiyan ^a   Sakthisekaran, Dhanapal ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

B(a)P; Glycoprotein; PCNA; Polyamines

Indexed keywords

BENZO[A]PYRENE; CROCETIN; GLYCOPROTEIN; POLYAMINE; ANTINEOPLASTIC AGENT; CAROTENOID; CYCLINE; HEXOSAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; GLYCOPROTEIN SYNTHESIS; IN VIVO STUDY; LUNG ADENOMA; LUNG CANCER; LUNG CARCINOGENESIS; MALE; MOUSE; NONHUMAN; POLYAMINE SYNTHESIS; TUMOR GROWTH; ADENOMA; ANIMAL; CHEMICALLY INDUCED DISORDER; LIVER; LUNG; LUNG TUMOR; METABOLISM; PATHOLOGY;

ANIMALIA; MUS; NICOTIANA TABACUM;

ADENOMA; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BENZO(A)PYRENE; CAROTENOIDS; GLYCOPROTEINS; HEXOSAMINES; LIVER; LUNG; LUNG NEOPLASMS; MALE; MICE; POLYAMINES; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 64549085416     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2666     Document Type: Article

References (40)

1. Abdullaev FI. 2001. Plant-derived agents against cancer. In Pharmacology and therapeutics in the new millennium Gupta SK (ed.). Narosa Publishing House: New Delhi, 345-354.
2. Bandyopadhyay M, Ganguly A. 1999. Serum and urine concentrations of diamine and polyamines in patients with uterine, ovarian, breast or rectal cancer. Med Sci Res 27: 645-647.
3. Basker D, Negbi M. 1983. The use of saffron. Econ Bot 37: 228-236.
4. Beckett WS. 1993. Epidemiology and etiology of lung cancer. Clin Chest Med 14: 1-15.
5. Chanda R, Ganguly AK. 1987. Diamine oxidase activity and tissue histamine content of human skin, breast and rectal carcinoma. Cancer Lett 34: 207-212.
6. Chang VC, Lin YL, Lee MJ, Show SJ, Wang CJ. 1996. Inhibitory effect of crocetin on benzo(a)pyrece genotoxicity and neoplastic transformation in C3H1OT1/2 cells. Anticancer Res 765: 3603-3608.
7. Cipolla B, Guille F, Moulinoux JP. 1993. Polyamine and prostatic carcinoma: Clinical and therapeutic implications. Eur Urol 24: 124-31.
8. Conklin KA. 2000. Dietary antioxidants during cancer chemotherapy: Impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 37: 1-18.
9. El-Salahy EM. 2002. Correlation between polyamines and apoptosis among Egyptian breast cancer patients. Clin Biochem 35: 555-560.
10. Endo Y. 1978. A simple and sensitive method of analysis of histamine, putrescine and polyamines without the use of an amino acid analyser. Anal Biochem 89: 235-46.
11. Farriol M, Segovia ST, Venero Y, Orta X. 2001. Role of poly- amines in cell proliferation in a colon carcinoma cell line. Nutrition 17: 934-938.
12. Fredlund JO, Oredsson SM. 1996. Impairment of DNA replication within one cell cycle after seeding of cells in the presence of a polyamine-biosynthesis inhibitor. Eur J Biochem 237: 539-544.
13. George LM, Boris P, Stefan J. 2007. PCNA, the Maestro of the replication fork. Cell 129: 665-679.
14. Herzfeld A, Greengard O. 1997. The effect of lymphoma and other neoplasms on hepatic and plasma enzymes of the host rat. Cancer Res 37: 231-238.
15. Hucks RM. 1983. Pathological and biochemical aspects of tumor promotion. Carcinogenesis 4: 1209-1214. Hynes RO. 1978. Cell surface proteins and malignant transformation. Biochem Biophys Acta 458: 73-107.
16. Janne J, Poso H, Rina A. 1978. Polyamines in rabbit growth and cancer. Biochim Biophys Acta 473: 241-247.
17. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. 2003. Cancer Statistics, CA. Cancer J Clin 53: 5-26.
18. Kelloff GJ, Crowell JA, Boone CW, Steele VE, Lubet RA, Greenwald P, Alberts DS, Covey JM, Doody LA, Knapp GG et al. 2004. Clinical development plan: beta-carotene and other carotenoids. J Cell Biochem 56: 110-140.
19. Magesh V, Prince Vijeya Singh J, Selvendiran K, Ekambaram G, Sakthisekaran D. 2006. Antitumour activity of crocetin in accordance to tumor incidence, antioxidant status, drug metabolizing enzymes and histopathological studies. Mol Cell Biochem 287: 127-135.
20. Momoi M, Kennett RH, Glick MC. 1980. A membrane glycoprotein from human neuroblastoma cells isolated with the use of a monoclonal antibody. J Biol Chem 255: 11914-11921.
21. Nadkarni KM. 1976. Crocus sativus, Nigella sativa. In Indian Materia Medica, Nadkarni KM (ed.). Popular Prakashan: Bombay; 386-411.
22. Naghma K, Farrukh A, Hasan M. 2008. Cancer Chemoprevention through Dietary Antioxidants: Progress and Promise. Anti- oxidants and Redox Signaling 10: 475-510.
23. Nair SC, Pannikar B, Pannikar KR. 1991. Antitumour activity of saffron (Crocus sativus). Cancer Lett 57: 109-14.
24. Niebes P. 1972. Determination of enzyme and degradation products of GAG metabolism in the serum of healthy and varicose subjects. Clin ChimActa 42: 399-408.
25. O'Hara M, Kiefer D, Farrell K, Kemper K. 1998. A review of 12 commonly used medicinal herbs. Arch Fam Med 7: 523-536.
26. Peter HM Hoet, Benoit N. 2000. Polyamines in the lung: polyamine uptake and polyamine-linked pathological or toxicological conditions. Am J Physiol Lung Cell Mol Physiol 278: 417-433.
27. Rachesky MH, Hard GC, Glick MC. 1982. Membrane glyco- peptides from chemically transformed cells: comparison between mesenchymal and epithelial cell lines derived from dimethylnitrosamine-treated rat kidney. Cancer Res 42: 39-43.
28. Rauscher FM, Sanders RA, Watkins JB. 2000. Effects of piperine on antioxidant pathways in tissues from normal and strepto- zotocin induced diabetic rats. J Biochem Molec Toxicol 14: 329-334.
29. Selvam S, Nagini S. 1995. Administration of the plasticizer di (2-ethylhexyl) phthalate alters glycoconjugate profile. Indian J Physiol Pharmacol 39: 252-254.
30. Selvendiran K, Banu SM, Sakthisekaran D. 2004. Protective effect of piperine on benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice. Clin Chim Acta 350: 73-78.
31. Stephen S, Pramod U, Mingyao W, Robin LB, Edward J, Mcintee, Patrick MJ, Kenney. 2002. Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L- cysteine and myo-inositol, individually and in combination. Carcinogenesis 29: 1455-1461.
32. Takami H, Nishoka K. 1980. The effect of glycosylation inhibitors on fc receptor mediated phagocytosis and carbohydrate incorporation by mouse peritoneal macrophages. Fed Proc 37: 1685-1691.
33. Thirunavukkarasu C, Sakthisekaran D. 2003. Influence of sodium selenite on glycoprotein contents in normal and N- nitrosodiethylamine initiated and phenobarbital promoted rat liver tumors. Pharmacol Res 48: 167-171.
34. Thomas T, Thomas TJ. 2001. Polyamines in cell growth and cell death, molecular mechanisms and therapeutic applications. Cellular Mol Life Sci 58: 244-258.
35. Unnikrishnan MC, Kuttan R. 1990. Tumor reducing and anticarcinogenic activity of selected spices. Cancer Lett 51: 85.
36. Wagner WD. 1974. More sensitive assay discriminating galacto- samine and glucosamine in mixtures. Anal Biochem 94: 394-397.
37. Wang CJ, Lee MJ, Chang MC, Lin JK. 1995. Inhibition of tumor promotion in benzo[a]pyrene-initiated CD-1 mouse skin by crocetin. Carcinogenesis 16: 187-191.
38. Warren L. 1954. The thiobarbituric acid assay of sialic acid. J Biol Chem 234: 1971-1975.
39. Williams GW. 1984. Modulation of chemical carcinogenesis by xenobiotics. Fund Appl Toxicol 4: 325-344.
40. Yano Y, Vano Y, Yajima S, Kumadaki I, Otani S, Hagiwara K. 2001. The suppression of ornithine decarboxylase expression and cell proliferation at the promotion stage of lung carcinogenesis in mice by alpha-tocopheryloxybutyric acid. Biochem Pharmacol 61: 1177-1181.